F. Joel Leong

Spiroindolone KAE609 for Falciparum and Vivax Malaria

Nicholas J. White, Sasithon Pukrittayakamee, Aung Pyae Phyo et al. · New England Journal of Medicine · 2014 · 244 citations · Full text

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis

Ujjini H. Manjunatha, Sumiti Vinayak, Jennifer A. Zambriski et al. · Nature · 2017 · 191 citations · Full text

Pharmacology, Medicine, Pathology +1

Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria

Nicholas J. White, Tran Thanh Duong, Chirapong Uthaisin et al. · New England Journal of Medicine · 2016 · 107 citations · Full text

A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

F. Joel Leong, Ruobing Li, Jay Prakash Jain et al. · Antimicrobial Agents and Chemotherapy · 2014 · 103 citations · Full text

Drug Safety, Healthy Adult Volunteers, Pharmacological Study +14

A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

F. Joel Leong, Rong Zhao, Shuqi Zeng et al. · Antimicrobial Agents and Chemotherapy · 2014 · 66 citations · Full text

Antiparasitic Agent, Abstract Kaf156, Malaria +18